MedTrace Logo

A Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia

NCT02963142 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2019-05-02

No results posted yet for this study

Summary

Severe community acquired pneumonia is common and associated with high mortality. Conventional microbiological diagnostics identify pathogens in approximately half of cases, which is inadequate for both clinical and epidemiological purposes. This study applies next-generation sequencing based metagenomic techniques to patients with extremely severe community acquired pneumonia, to investigate the microbiome of severe community acquired pneumonia and evaluate metagenomic approaches as diagnostic tools.

Conditions

  • Community Acquired Pneumonia
  • Respiration Failure
  • Pneumonia

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ajit Lalvani, MBBS,MRCP,FRCP · Imperial College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-10-31
Completion
2018-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963142 on ClinicalTrials.gov